[Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|March 1, 1992
PubMed

Insights

New Klebsiella bacteriophage preparations are safe and effective for treating infections like ozena and rhinoscleroma. Clinical studies show these non-toxic bacteriophages offer a viable therapeutic option for various Klebsiella-related conditions.

Area of Science:

  • Microbiology
  • Virology
  • Immunology

Context:

  • Klebsiella species are significant human pathogens.
  • Bacteriophage therapy offers an alternative to antibiotics.
  • Development of targeted antimicrobial agents is crucial.

Purpose:

  • To obtain purified Klebsiella bacteriophage preparations.
  • To evaluate the safety and efficacy of these bacteriophage preparations.
  • To assess their therapeutic potential in treating Klebsiella infections.

Summary:

  • Monovalent and polyvalent Klebsiella bacteriophage preparations were successfully obtained.
  • Pre-clinical studies confirmed the non-toxic and safe profile in laboratory animals.
  • Clinical trials in 109 patients demonstrated safety, non-reactogenicity, and effectiveness against ozena, rhinoscleroma, and other Klebsiella infections.

Impact:

  • Provides novel, safe, and effective bacteriophage-based therapeutics for Klebsiella infections.
  • Offers a promising alternative or adjunct to antibiotic therapy.
  • Contributes to the management of challenging infectious diseases caused by Klebsiella species.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
Bacteriophages of the Human Virome01:23

Bacteriophages of the Human Virome

Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...